Aidigong Maternal & Child Health (SEHK:286) - Hisse Senedi Fiyatı, Haberler ve Analizler

286 Stoklara Genel Bakış

Bir yatırım holding şirketi olan Aidigong Maternal & Child Health Limited, Çin Halk Cumhuriyeti'nde doğum sonrası bakım ve sağlık hizmetleri sunmaktadır.

Şirket hakkında

286 temel anali̇z
Kar Tanesi Skoru
Değerleme	4/6
Gelecekteki Büyüme	0/6
Geçmiş Performans	0/6
Finansal Sağlık	3/6
Temettüler	0/6

Ödüller

Adil değer tahminimizden 41.6% daha düşük bir oranda işlem görüyor

Risk Analizi

Kazançlar son 5 yılda yılda 17.5% oranında azaldı

Hissedarlar geçen yıl sulandırıldı

Anlamlı bir piyasa değeri yok ( HK$297M )

Son 3 ayda dalgalı hisse senedi fiyatı

Aidigong Maternal & Child Health Limited Rakipler

Human Health Holdings

SEHK:1419

HK$307.4m

Bamboos Health Care Holdings

SEHK:2293

HK$261.6m

Clarity Medical Group Holding

SEHK:1406

HK$203.6m

Meihao Medical Group

SEHK:1947

HK$225.1m

Fiyat Geçmişi ve Performans

için tüm zamanların en yüksek seviyelerinin, değişikliklerin ve fiyat düşüşlerinin özeti Aidigong Maternal & Child Health
Tarihsel hisse senedi fiyatları
Güncel Hisse Fiyatı	HK$2.01
52 Haftanın En Yüksek Seviyesi	HK$14.40
52 Haftanın En Düşük Seviyesi	HK$1.25
Beta	0.43
11 Aylık Değişim	-43.70%
3 Aylık Değişim	1.01%
1 Yıllık Değişim	-79.90%
33 Yıllık Değişim	-94.29%
5 Yıllık Değişim	-91.34%
Halka arzdan bu yana değişim	-100.00%

Son Haberler & Güncellemeler

Pinning Down Aidigong Maternal & Child Health Limited's (HKG:286) P/S Is Difficult Right Now

Sep 25

Recent updates

Pinning Down Aidigong Maternal & Child Health Limited's (HKG:286) P/S Is Difficult Right Now

Sep 25

Investors Don't See Light At End Of Aidigong Maternal & Child Health Limited's (HKG:286) Tunnel And Push Stock Down 26%

Jun 06

Take Care Before Jumping Onto Aidigong Maternal & Child Health Limited (HKG:286) Even Though It's 28% Cheaper

Mar 22

A Look At The Fair Value Of Aidigong Maternal & Child Health Limited (HKG:286)

Jul 06

Aidigong Maternal & Child Health Limited (HKG:286) Looks Inexpensive After Falling 28% But Perhaps Not Attractive Enough

Jun 14

Calculating The Intrinsic Value Of Aidigong Maternal & Child Health Limited (HKG:286)

Mar 27

Is Aidigong Maternal & Child Health Limited (HKG:286) Trading At A 24% Discount?

Dec 21

Is Aidigong Maternal & Child Health (HKG:286) Using Debt In A Risky Way?

Oct 13

Estimating The Fair Value Of Aidigong Maternal & Child Health Limited (HKG:286)

Sep 02

Aidigong Maternal & Child Health (HKG:286) Has A Somewhat Strained Balance Sheet

Jun 29

Aidigong Maternal & Child Health (HKG:286) Use Of Debt Could Be Considered Risky

Aug 31

Do Institutions Own Aidigong Maternal & Child Health Limited (HKG:286) Shares?

Feb 21

Is Aidigong Maternal & Child Health Limited's (HKG:286) Stock Price Struggling As A Result Of Its Mixed Financials?

Jan 17

Aidigong Maternal & Child Health's(HKG:286) Share Price Is Down 14% Over The Past Three Years.

Dec 12

Hissedar Getirileri

	286	HK Healthcare	HK Pazar
7D	-9.9%	4.2%	3.9%
1Y	-79.9%	-18.6%	19.4%

Getiri vs. Endüstri: 286 geçen yıl % -18.6 oranında getiri sağlayan Hong Kong Healthcare sektörünün gerisinde kaldı.

Getiri vs Piyasa: 286 geçen yıl % 19.4 oranında getiri sağlayan Hong Kong Piyasasının altında performans gösterdi.

Fiyat Oynaklığı

Is 286's price volatile compared to industry and market?
286 volatility
286 Average Weekly Movement	17.5%
Healthcare Industry Average Movement	8.4%
Market Average Movement	8.9%
10% most volatile stocks in HK Market	18.9%
10% least volatile stocks in HK Market	4.2%

İstikrarlı Hisse Senedi Fiyatı: 286 hisse senedi fiyatı son 3 aydır dalgalı bir seyir izliyor.

Zaman İçindeki Volatilite: 286 'nin haftalık oynaklığı ( 17% ) geçen yıl boyunca sabit kaldı, ancak hala Hong Kong hisselerinin %75'inden yüksek.

Şirket Hakkında

Kuruldu	Çalışanlar	CEO	Web sitesi
1990	1,338	Aier Wang	www.aidigong.hk

Bir yatırım holding şirketi olan Aidigong Maternal & Child Health Limited, Çin Halk Cumhuriyeti'nde doğum sonrası bakım ve sağlık hizmetleri sunmaktadır. Şirket, Doğum Sonrası Bakım Hizmetleri, Sağlık Endüstrisi ve Diğer segmentleri aracılığıyla faaliyet göstermektedir. Anne ve çocuk sağlığı hizmetleri; tıbbi yaşlanma karşıtı hizmetler; sağlık sektörü yatırım hizmetleri; ve sağlık mülk geliştirme hizmetlerinin yanı sıra yönetim, yatırım ve finans hizmetleri sunmaktadır.

Aidigong Maternal & Child Health Limited Temel Bilgiler Özeti

Aidigong Maternal & Child Health'un kazançları ve gelirleri piyasa değeriyle nasıl karşılaştırılır?
286 temel i̇stati̇sti̇kler
Piyasa değeri	HK$297.15m
Kazançlar(TTM)	-HK$192.96m
Gelir(TTM)	HK$522.09m

0.6x

P/S Oranı

-1.5x

F/K Oranı

286 aşırı değerli mi?

Gerçeğe Uygun Değer ve değerleme analizine bakınız

Kazanç ve Gelir

En son kazanç raporundan temel karlılık istatistikleri (TTM)
286 gelir tablosu (TTM)
Gelir	HK$522.09m
Gelir Maliyeti	HK$424.06m
Brüt Kâr	HK$98.03m
Diğer Giderler	HK$290.99m
Kazançlar	-HK$192.96m

Son Raporlanan Kazançlar

Jun 30, 2024

Sonraki Kazanç Tarihi

n/a

Hisse başına kazanç (EPS)	-1.31
Brüt Marj	18.78%
Net Kâr Marjı	-36.96%
Borç/Özkaynak Oranı	78.3%

286 uzun vadede nasıl bir performans gösterdi?

Geçmiş performansı ve karşılaştırmayı görün

286 Stoklara Genel Bakış

Ödüller

Risk Analizi

Aidigong Maternal & Child Health Limited Rakipler

SEHK:1419

HK$307.4m

SEHK:2293

HK$261.6m

SEHK:1406

HK$203.6m

SEHK:1947

HK$225.1m

Fiyat Geçmişi ve Performans

Son Haberler & Güncellemeler

Now 33% undervalued

Now 26% undervalued

First half 2024 earnings released: HK$0.33 loss per share (vs HK$0.22 loss in 1H 2023)

New minor risk - Share price stability

Pinning Down Aidigong Maternal & Child Health Limited's (HKG:286) P/S Is Difficult Right Now

Aidigong Maternal & Child Health Limited(SEHK:286) dropped from S&P Global BMI Index

Recent updates

Now 33% undervalued

Now 26% undervalued

First half 2024 earnings released: HK$0.33 loss per share (vs HK$0.22 loss in 1H 2023)

New minor risk - Share price stability

Pinning Down Aidigong Maternal & Child Health Limited's (HKG:286) P/S Is Difficult Right Now

Aidigong Maternal & Child Health Limited(SEHK:286) dropped from S&P Global BMI Index

First half 2024 earnings released: HK$0.33 loss per share (vs HK$0.22 loss in 1H 2023)

Aidigong Maternal & Child Health Limited to Report First Half, 2024 Results on Aug 30, 2024

Aidigong Maternal & Child Health Limited, Annual General Meeting, Jun 28, 2024

Investors Don't See Light At End Of Aidigong Maternal & Child Health Limited's (HKG:286) Tunnel And Push Stock Down 26%

Full year 2023 earnings: EPS and revenues miss analyst expectations

Take Care Before Jumping Onto Aidigong Maternal & Child Health Limited (HKG:286) Even Though It's 28% Cheaper

Aidigong Maternal & Child Health Limited has filed a Follow-on Equity Offering in the amount of HKD 62.09021 million.

Aidigong Maternal & Child Health Limited to Report Fiscal Year 2023 Results on Mar 28, 2024

New minor risk - Insider selling

Chairman & CEO recently sold HK$8.4m worth of stock

New major risk - Share price stability

Chairman & CEO recently bought HK$1.4m worth of stock

New minor risk - Shareholder dilution

Chairman of the Board & CEO recently bought HK$247k worth of stock

Aidigong Maternal & Child Health Limited Announces Board and Committee Changes

Aidigong Maternal & Child Health Limited Announces Resignation of Guo Qifei Has as Non-Executive Director

First half 2023 earnings released: HK$0.005 loss per share (vs HK$0.014 loss in 1H 2022)

First half 2023 earnings released: HK$0.005 loss per share (vs HK$0.014 loss in 1H 2022)

Aidigong Maternal & Child Health Limited Provides Earnings Guidance for the Six Months Ended June 30, 2023

Aidigong Maternal & Child Health Limited to Report First Half, 2023 Results on Aug 31, 2023

Executive Director recently bought HK$6.3m worth of stock

A Look At The Fair Value Of Aidigong Maternal & Child Health Limited (HKG:286)

Aidigong Maternal & Child Health Limited (HKG:286) Looks Inexpensive After Falling 28% But Perhaps Not Attractive Enough

Full year 2022 earnings: EPS and revenues miss analyst expectations

Calculating The Intrinsic Value Of Aidigong Maternal & Child Health Limited (HKG:286)

Now 22% undervalued after recent price drop

Aidigong Maternal & Child Health Limited Announces Director Appointments

Is Aidigong Maternal & Child Health Limited (HKG:286) Trading At A 24% Discount?

Aidigong Maternal & Child Health Limited announced that it expects to receive HKD 224.719102 million in funding from Zhuhai Deyou Bohui Enterprise Management Consulting (Limited Partnership)

Now 24% undervalued after recent price drop

Aidigong Maternal & Child Health Limited Announces Executive Changes

Price target decreased to HK$0.60

Less than half of directors are independent

Is Aidigong Maternal & Child Health (HKG:286) Using Debt In A Risky Way?

First half 2022 earnings released: HK$0.014 loss per share (vs HK$0.006 profit in 1H 2021)

Now 25% undervalued

Estimating The Fair Value Of Aidigong Maternal & Child Health Limited (HKG:286)

First half 2022 earnings released: HK$0.014 loss per share (vs HK$0.006 profit in 1H 2021)

Aidigong Maternal & Child Health Limited Provides Consolidated Earnings Guidance for the Six Months Ended 30 June 2022

Aidigong Maternal & Child Health Limited Announces Resignation of Wong Kin Man as a Non-Executive Director

Aidigong Maternal & Child Health (HKG:286) Has A Somewhat Strained Balance Sheet

Aidigong Maternal & Child Health Limited, Annual General Meeting, Jun 28, 2022

Aidigong Maternal & Child Health Limited Announces Resignation of Yang Zhibo as Non-Executive Director

Price target decreased to HK$0.65

Less than half of directors are independent

Full year 2021 earnings: EPS and revenues miss analyst expectations

Chairman of the Board & CEO recently bought HK$1.2m worth of stock

First half 2021 earnings released: EPS HK$0.006 (vs HK$0.007 in 1H 2020)

Independent Non Executive Director Yang Guang Mai has left the company

Aidigong Maternal & Child Health (HKG:286) Use Of Debt Could Be Considered Risky

First half 2021 earnings released: EPS HK$0.006 (vs HK$0.007 in 1H 2020)

Aidigong Maternal & Child Health Limited has completed a Follow-on Equity Offering in the amount of HKD 117.8 million.

An unknown buyer entered into an agreement to acquire 49% stake Shenzhen Wanqi Marine Bio Tech Company Limited from Aidigong Maternal & Child Health Limited (SEHK:286) for HKD 25 million.